Strata Critical Medical (SRTA) Intangibles (2020 - 2026)

Strata Critical Medical has disclosed Intangibles across 7 years of filings, most recently posting $46.3 million for Q1 2026.

• In Q1 2026, Intangibles rose 242.34% year-over-year to $46.3 million; the TTM figure through Mar 2026 stood at $46.3 million (up 242.34% YoY), while the FY2025 annual figure was $47.5 million, up 496.46% from the prior year.
• Intangibles declined to $46.3 million in Q1 2026, from $47.5 million in the prior quarter.
• Over the last five years, Intangibles for SRTA reached as high as $49.8 million in Q3 2025 and fell as low as $8.0 million in Q4 2024.
• The 5-year median for Intangibles is $23.7 million (2022), against an average of $30.5 million.
• Annual changes were most pronounced in 2022 — Intangibles jumped 1467.4% — and 2024, when it plunged 68.81%.
• A 5-year view of Intangibles shows it stood at $46.4 million in 2022, then plunged by 55.74% to $20.5 million in 2023, then plunged by 61.19% to $8.0 million in 2024, then soared by 496.46% to $47.5 million in 2025, then retreated by 2.51% to $46.3 million in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $46.3 million, $47.5 million, and $49.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.